Meta's US$14.8 billion Scale AI deal latest test of AI partnerships
[NEW YORK] Facebook owner Meta's US$14.8 billion investment in Scale AI and hiring of the data-labeling startup's chief executive offiecer will test how the Trump administration views so-called acquihire deals, which some have criticized as an attempt to evade regulatory scrutiny. The deal, announced on Thursday (Jun 12), was Meta's second-largest investment to date. It gives the owner of Facebook a 49 per cent nonvoting stake in Scale AI, which uses gig workers to manually label data and includes among its customers Meta competitors Microsoft and ChatGPT creator OpenAI.
Unlike an acquisition or a transaction that would give Meta a controlling stake, the deal does not require a review by US antitrust regulators. However, they could probe the deal if they believe it was structured to avoid those requirements or harm competition. The deal appeared to be structured to avoid potential pitfalls, such as cutting off competitors' access to Scale's services or giving Meta an inside view into rivals' operations – though Reuters exclusively reported on Friday that Alphabet's Google has decided to sever ties with Scale in light of Meta's stake, and other customers are looking at taking a step back.
In a statement, a Scale AI spokesperson said its business, which spans work with major companies and governments, remains strong, as it is committed to protecting customer data. The company declined to comment on specifics with Google.
Alexandr Wang, Scale's 28-year-old CEO who is coming to Meta as part of the deal, will remain on Scale's board but will have appropriate restrictions placed around his access to information, two sources familiar with the move confirmed. Large tech companies likely perceive the regulatory environment for AI partnerships as easier to navigate under President Donald Trump than under former President Joe Biden, said William Kovacic, director of the competition law center at George Washington University.
Trump's antitrust enforcers have said they do not want to regulate how AI develops, but have also displayed a suspicion of large tech platforms, he added.
'That would lead me to think they will keep looking carefully at what the firms do. It does not necessarily dictate that they will intervene in a way that would discourage the relationships,' Kovacic said.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
Federal Trade Commission probes into past 'aquihire' deals appear to be at a standstill. Under the Biden administration, the FTC opened inquiries into Amazon's deal to hire top executives and researchers from AI startup Adept, and Microsoft's US$650 million deal with Inflection AI. The latter allowed Microsoft to use Inflection's models and hire most of the startup's staff, including its co-founders.
Amazon's deal closed without further action from the regulator, a source familiar with the matter confirmed. And, more than a year after its initial inquiry, the FTC has so far taken no enforcement action against Microsoft over Inflection, though a larger probe over practices at the software giant is ongoing.
A spokesperson for the FTC declined to comment on Friday.
David Olson, a professor who teaches antitrust law at Boston College Law School, said it was smart of Meta to take a minority nonvoting stake.
'I think that does give them a lot of protection if someone comes after them,' he said, adding that it was still possible that the FTC would want to review the agreement. The Meta deal has its skeptics. US Senator Elizabeth Warren, a Democrat from Massachusetts who is probing AI partnerships involving Microsoft and Google, said Meta's investment should be scrutinised.
'Meta can call this deal whatever it wants – but if it violates federal law because it unlawfully squashes competition or makes it easier for Meta to illegally dominate, antitrust enforcers should investigate and block it,' she said in a statement on Friday.
While Meta faces its own monopoly lawsuit by the FTC, it remains to be seen whether the agency will have any questions about its Scale investment. The US Department of Justice's antitrust division, led by former JD Vance adviser Gail Slater, recently started looking into whether Google's partnership with chatbot creator Character.AI was designed to evade antitrust review, Bloomberg News reported. The DOJ is separately seeking to make Google give it advance notice of new AI investments as part of a proposal to curb the company's dominance in online search. REUTERS
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Times
an hour ago
- Business Times
Port of LA imports drop 19% in May as tariffs hit US businesses
Import volumes through the busiest trade hub in the US fell 19 per cent from the month before, a fallout from President Donald Trump's tariffs. 'It's very slow here seasonally,' Port of Los Angeles executive director Gene Seroka told reporters last Friday (Jun 13). Seroka warned that US businesses are facing high tariffs and uncertainty during what is typically the start of the peak season, and the consequences are likely to show up on store shelves in a few months. 'We've already blown past summer fashion and looking forward now to back to school and Halloween before the all important year-end holidays,' Seroka said. 'Cargo for those micro seasons needs to be here on the ground right now. I don't necessarily see that in inventory levels.' The drop in port activity came as importers and retailers – especially those with business in China – grappled with the uncertainty of Trump's trade war. Tariffs on goods from China were as high as 145 per cent in April, when many of the goods arriving in Southern California in May would have left Asian ports. In May, cargo handlers at the Port of Los Angeles processed a total of about 717,000 equivalent units, or TEUs. About 356,000 of those were imports, a 19 per cent drop compared to a month ago and 9 per cent lower than May 2024, Seroka said. Exports through Los Angeles fell to just over 120,000 containers, marking the sixth straight month of year-on-year declines as other countries responded with retaliatory tariffs, particularly for US agricultural goods, Seroka said. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up While import flows may pick up again as importers rush to bring goods in during a temporary agreement between the US and China to lower the highest of the tariffs, import levies on goods from China remain prohibitively high for many businesses. 'When all is said and done, buying products out of China right now still costs one and a half times more than it did earlier this year, making products of all types extremely expensive,' Seroka said. Despite the cancelled and delayed orders, importers still paid a record US$23 billion in customs duties in May, US Treasury data released last week showed. That translates to an average effective tariff rate of roughly 7.5-8 per cent, up from 2.5 per cent at the beginning of the year, according to Ernie Tedeschi, director of economics at Yale University's Budget Lab and a former Biden administration official. And there's still a ways to go before all of the tariffs announced by the Trump administration are implemented, Tedeschi said at the Port of Los Angeles briefing. 'We estimate that current policy is equivalent to a 15.5 per cent average effective tariff rate, including the new announcements for 2025 and the levels prior to them.' BLOOMBERG
Business Times
2 hours ago
- Business Times
China's biotech moment ignites a 60% stock rally that beats AI
China's biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds are tipping further gains. The Hang Seng Biotech Index has surged more than 60 per cent since the start of January amid investor enthusiasm over a pair of billion-dollar deals involving foreign firms licensing Chinese drugs. Share gains at two highly anticipated listings of local producers have further burnished the sector's appeal. 'China biotech is no longer just an emerging story – unlike 10 years ago – it is now a disruptive force reshaping global drug innovation,' said Yiqi Liu, senior investment analyst at Exome Asset Management in New York. 'The science is real, the economics are compelling, and the pipeline is starting to deliver.' The surge in China-listed biotech firms is further evidence that the mainland is becoming a centre for global innovation. The rally in the sector this year outpaces the 17 per cent gain in China's tech stocks that was driven by the release of DeepSeek's breakthrough artificial-intelligence app in January. A major reason for the share gains were two mega-sized licensing deals. Pfizer said on May 19 that it had agreed to pay a record US$1.25 billion to license an experimental cancer drug from China's 3SBio, and also invest US$100 million in the firm's shares. Two weeks later, Bristol-Myers Squibb said it would pay Germany's BioNTech as much as US$11.5 billion to license a cancer drug that BioNTech had itself licensed from China's Biotheus in 2023. Some of the gains in biotech shares this year have been stratospheric. 3SBio has surged 283 per cent, topping a Bloomberg gauge of global biotech stocks. RemeGen, which develops antibody drugs, has climbed more than 270 per cent after saying it was approached by multinational pharmaceutical firms for potential licensing deals. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up China's growing influence through pharmaceutical mergers and acquisitions and deal-making is also causing investors to take note. In the first quarter alone, the value of such deals involving local players doubled from the year before to US$36.9 billion. That amount made up more than half the global total of US$67.5 billion. Chinese biotech companies are having 'their own DeepSeek moment', said Dong Chen, chief Asia strategist at Pictet Wealth Management in Hong Kong. There is more upside from here, he said. Investor interest in biotech – which involves the use of living organisms to make medicines and other products – can be seen in the big runup at recent initial public offerings. Shares of Duality Biotherapeutics, which develops cancer treatments, more than doubled on their first day of trading in Hong Kong on Apr 15. Jiangsu Hengrui Pharmaceuticals, the nation's largest drugmaker by market value, saw its stock jump 25 per cent on its May 23 debut, even after being issued at the top end of the marketed range. Duality has now risen 189 per cent since its IPO, while Jiangsu has gained 31 per cent. Still, some say the rally may be getting stretched. 'Bears, mostly healthcare specialists, plan to take profit at this point, and some investors prefer the healthcare laggers with capability of constant dividend payout and stable revenue growth,' Bank of America analysts including Ethan Cui in Hong Kong wrote in a research note this month. Some investors also said they viewed the rush of recent licensing deals as a one-off, and they were refusing to grant valuation multiples to the companies, the analysts wrote. Talent returns While the recent ratcheting up of trade tensions between the US and China has been a negative for many mainland firms, it's also resulted in talent flowing back to China and creating more research-and-development capability, according to Nicholas Chui, a Chinese equity fund manager at Franklin Templeton in Hong Kong. Jefferies is also bullish, saying the increase in US tariffs is unlikely to prove an obstacle to Chinese biotech firms. Many of the Chinese biotech companies already have US partners and are therefore considered as service providers rather than product exporters, said Cui Cui, head of Asia healthcare research at the company in New York. BLOOMBERG
New Paper
3 hours ago
- New Paper
Singapore start-up on a green mission to keep mobile phones in use for longer
Singaporeans are replacing their phones every 2.7 years, contributing to some 2.9 million mobile phones being stowed away, a new study shows. But one Singapore start-up is hoping to change this and keep phones in circulation for five years here. This will be even longer than the global smartphone replacement cycle of 3.5 years on average. Cinch plans to meet this target by renting out instead of selling the devices to consumers, ensuring that the returned units at the end of the rental period are refurbished to get a new lease of life with another user. "We're trying to extend the useful life of these devices beyond the average refresh rate," said Mr Mahir Hamid, chief executive and co-founder of Cinch, which commissioned the study to better understand consumer behaviour. Its study, conducted between late 2024 and early 2025, involved interviews with firms that handle e-waste and used devices, as well as a survey of 500 Singapore-based respondents. Fresh from raising US$28.8 million (S$37 million) in funding led by Monk's Hill Ventures, Cinch is now actively pursuing consumers, letting them pay a monthly fee to rent the latest premium models of phones, laptops and other devices. Cinch will also foot 90 per cent of the repair cost of devices damaged due to accidents. For instance, the latest Samsung Galaxy S25 Edge with 512GB storage is available from Cinch for a rental fee of $70 a month over two years. At the end of two years, consumers would have paid $1,680. The same model can be bought from Samsung for $1,808. An Apple iPhone 16 Pro Max with 512GB storage can be rented from Cinch for $120 a month over 12 months. This will amount to a total of $1,440 at the end of the year. The same model costs $2,199 upfront from the Apple store. Customers can also buy direct from Samsung and Apple with an interest-free instalment plan, but it would require them to have a credit card from specific banks such as DBS, OCBC or UOB. "There is a massive segment of the population for which a $2,000 to $3,000 purchase can be a significant proportion of their monthly salary," said Mr Hamid. "A subscription model allows them to access the premium device." Cinch, which has been operating here since 2023, has been leasing mostly to businesses such as those in the retail, logistics, information technology and public relations sectors. Around 10,000 devices such as laptops, smartphones and tablets have been leased, most of which were returned and refurbished for a second or third customer. "Every refurbished unit needs to be as good as new," said Mr Hamid. "If it doesn't meet our standards, it doesn't go back into circulation." He said that all returned devices undergo a professional diagnostic sweep and complete data wipe so users do not have to worry about privacy leaks. Customers can buy their rented devices from Cinch if they wish, but it would likely cost more than buying from retailers such as Shopee or Lazada, said Mr Hamid, urging users to rent instead. Cinch has also partnered with waste management firm Alba Group since the start of 2025 to collect and recycle devices that can no longer be refurbished for new leases. During recycling, valuable materials such as precious metals and plastics are extracted from the e-waste. Singapore generates more than 60,000 tonnes of e-waste a year, according to a report by the National Environment Agency in 2018. This is equivalent to 73 mobile phones disposed of per person in Singapore. Slowing down the device replacement cycle will reduce the overall volume of electronic waste that needs to be collected, sorted and processed, an Alba spokesperson told The Straits Times. "Alba supports efforts like Cinch's to keep electronic devices in circulation for a longer period, as it aligns with our mission to reduce e-waste and promote a circular economy in Singapore," said the spokesperson. The leadership team of Cinch, which has been operating in Singapore since 2023. PHOTO: CINCH The leasing of laptops, smartphones and tablets has become a standard practice among some businesses, as it allows them to access the latest technology without incurring huge upfront costs. Leasing is also a way of reducing depreciating assets. Leasing firms typically cover a device's configuration, maintenance, repair and eco-friendly disposal. Telcos Singtel and StarHub have been leasing devices to businesses since 2020 and 2021 respectively, while M1 does so only as part of a more comprehensive suite of tech services. Singtel started leasing devices to consumers in 2018, but ceased the programme in 2022. Mr Keith Leong, Singtel's managing director of enterprise, said consumers find that they get better value from buying devices bundled with mobile plans. But businesses in sectors such as government, infocomm and aviation continue to lease from Singtel. While the device leasing meets the specific needs of some businesses, many consumers still choose to buy devices as it gives them full ownership and control, which can be cost-effective over the long run, said Mr Leong. "Ultimately, both models provide valuable pathways to equip a mobile workforce effectively," he said. Other rental firms such as Circular and have also been in the market since 2021 to wean consumers from device ownership. Apart from renting out phones, laptop, and gaming consoles, also rents out home appliances such as digital door locks and washing machines. Leasing an iPhone 16 Pro Max with 512GB storage space would cost between $69 and $82 a month for two years from Circular, depending on the phone's condition. The same model would cost between $92 and $99 a month for two years from Cinch's adviser Arvin Singh said that Netflix and Grab have proven that ownership of storage discs and cars, respectively, is not essential. "Netflix for many years now has disrupted ownership of DVDs and hardware... So I think it's not a strange concept for consumers. When it comes to phones, maybe a bit more education is required," said Mr Singh. However, Ms Tracy Tsai, vice-president analyst of consulting firm Gartner, said that phones cannot be compared to DVDs, cars or bicycles as phones carry confidential personal data. The cost-effectiveness of renting also comes into question if users upgrade frequently, she added. "But if users want to chase the latest phone every year, renting might be less of an issue."
